New survey reveals Americans' perception of the growing need for plasma-derived medicines

A new survey during International Plasma Awareness Week reveals a growing recognition among Americans of the critical need for blood plasma-derived medicines in treating immunodeficiency disorders.

International Plasma Awareness Week runs from October 6-10, 2025, emphasizing the importance of blood plasma in developing lifesaving therapies.
The survey indicates that 78% of Americans believe plasma-derived medicines are crucial for treating patients with immunodeficiency disorders, highlighting their significance in health care.
Over 50% of respondents reported a personal connection to someone who relies on antibody therapies derived from blood plasma, illustrating the widespread impact of these treatments.
The Plasma Protein Therapeutics Association organized this survey to honor plasma donors and educate the public on the role of plasma in health care advancements.

Why It Matters

This survey underscores the critical role that blood plasma plays in health care, particularly for patients with immunodeficiency. As awareness grows, more individuals may feel compelled to donate, potentially increasing the supply of necessary plasma-derived medicines. The ongoing need for these therapies suggests that public engagement and education will be essential in supporting health care systems and patient outcomes.